The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Sex differences in Parkinson’s disease
Open accessAbstract
Parkinson's disease (PD) displays a greater prevalence and earlier age at onset in men. This review addresses the concept that sex differences in PD are determined, largely, by biological sex differences in the NSDA system which, in turn, arise from hormonal, genetic and environmental influences. Current therapies for PD rely on dopamine replacement strategies to treat symptoms, and there is an urgent, unmet need for disease modifying agents. As a significant degree of neuroprotection against the early stages of clinical or experimental PD is seen, respectively, in human and rodent females compared with males, a better understanding of brain sex dimorphisms in the intact and injured NSDA system will shed light on mechanisms which have the potential to delay, or even halt, the progression of PD. Available evidence suggests that sex-specific, hormone-based therapeutic agents hold particular promise for developing treatments with optimal efficacy in men and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–232 of 232
Lubomski, M., Louise Rushworth, R., Lee, W., Bertram, K., & Williams, D. R. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.05.015 · Cited by 41
Al-Sweidi, S., Morissette, M., Bourque, M., & Paolo, T. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.031 · Cited by 40
Pienaar, I. S., Kellaway, L. A., Russell, V. A., Smith, A. D., Stein, D. J., Zigmond, M. J., & Daniels, W. M. U. (2008) · Stress · doi:10.1080/10253890801890721 · Cited by 40
Self-citationKlink, R., Robichaud, M., & Debonnel, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00218-6 · Cited by 39
Methamphetamine–gonadal steroid hormonal interactions:
Dluzen, D. E., Anderson, L. I., & Pilati, C. F. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00187-3 · Cited by 38
Ciesielska, A., Joniec‐Maciejak, I., Kurkowska‐Jastrzębska, I., Cudna, A., Przybyłkowski, A. M., Członkowska, A., & Członkowski, A. (2009) · Inflammation Research · doi:10.1007/s00011-009-0026-6 · Cited by 38
Unconventional effects of estrogen uncovered
Dluzen, D. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.001 · Cited by 38
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice
Rodríguez‐Navarro, J. A., Gómez, A., Rodal, I., Perucho, J., Martínez, A., Furió, V., Ampuero, I., Casarejos, M. J., Solano, R. M., de Yébenes, J. G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn210 · Cited by 38
Ferraz, A. C., Xavier, L. L., Hernandes, S., Sulzbach, M. L., Viola, G. G., Anselmo-Franci, J. A., Achaval, M., & Cunha, C. D. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03198-6 · Cited by 37
Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice
Lewis, C., & Dluzen, D. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.011 · Cited by 36
Clark, A. J., Ritz, B. R., Prescott, E., & Rod, N. H. (2013) · European Journal of Neurology · doi:10.1111/ene.12117 · Cited by 35
Ferraz, A. C., Matheussi, F., Szawka, R. E., Rizelio, V., Delattre, A. M., Rigon, P., Hermel, É. D. E. S., Xavier, L. L., Achaval, M., & Anselmo-Franci, J. A. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9575-7 · Cited by 35
Role of Familial, Environmental and Occupational Factors in the Development of Parkinson’s Disease
Das, K., Ghosh, M., Nag, C., Nandy, S. P., Banerjee, M., Datta, M., Devi, G., & Chaterjee, G. (2011) · Neurodegenerative Diseases · doi:10.1159/000323797 · Cited by 33
Yu, L., Kuo, Y., Cherng, C. G., Chen, H.-H., & Hsu, C.-H. (2002) · Neuroendocrinology · doi:10.1159/000057337 · Cited by 31
Virdee, K., McArthur, S., Brischoux, F., Caprioli, D., Ungless, M. A., Robbins, T. W., Dalley, J. W., & Gillies, G. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.196 · Cited by 30
Self-citationDluzen, D. E., Jain, R., & Liu, B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010094.x · Cited by 29
Bassilana, F., Mace, N., Li, Q., Stutzmann, J. M., Gross, C. E., Pradier, L., Bénavidès, J., Ménager, J., & Bézard, E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.005 · Cited by 29
Vadász, C., Baker, H., Fink, S. J., & Reis, D. J. (1985) · Journal of Neurogenetics · doi:10.3109/01677068509100151 · Cited by 28
Pienaar, I. S., Lu, B., & Schallert, T. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.009 · Cited by 27
Self-citationVariants in estrogen‐related genes and risk of Parkinson's disease
Chung, S. J., Armasu, S. M., Biernacka, J. M., Lesnick, T. G., Rider, D. N., Cunningham, J. M., & Maraganore, D. M. (2011) · Movement Disorders · doi:10.1002/mds.23604 · Cited by 27
Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys
Morissette, M., & Paolo, T. D. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21977 · Cited by 27
Ji, J., & Dluzen, D. E. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0017-0 · Cited by 25
Cordellini, M. F., Piazzetta, G., Pinto, K. C., Delattre, A. M., Matheussi, F., Carolino, R. O. G., Szawka, R. E., Anselmo-Franci, J. A., & Ferraz, A. C. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0428-z · Cited by 22
Moroz, I. A., Rajabi, H., Rodaros, D., & Stewart, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00974-0 · Cited by 21
Bourque, M., Dluzen, D. E., & Paolo, T. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.009 · Cited by 20
Control of mitochondrial integrity in Parkinson’s disease
Vives-Bauzá, C., Tocilescu, M. A., deVries, R. L. A., Wolken, D. M. A., Jackson-Lewis, V. R., & Przedborski, S. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83006-7 · Cited by 20
Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease
Maraganore, D. M., Farrer, M. J., McDonnell, S. K., Elbaz, A., Schaid, D. J., Hardy, J., & Rocca, W. A. (2001) · Movement Disorders · doi:10.1002/mds.1253 · Cited by 17
Calder, S. A., Ebmeier, K. P., Stewart, L., Crawford, J. R., & BESSON, J. A. O. (1991) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930061008 · Cited by 15
Vadász, C. (1988) · Hormones and Behavior · doi:10.1016/0018-506x(88)90056-6 · Cited by 12
Pienaar, I. S., & Chinnery, P. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.010 · Cited by 12
Self-citationPeripheral vs. Central Sex Steroid Hormones in Experimental Parkinson?s Disease
McArthur, S., & Gillies, G. E. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00082 · Cited by 10
Self-citationXiao (1998) · doi:10.1002/(sici)1098-2396(199808)29:4
Cited by
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Astrocyte reactivity and reactive astrogliosis: costs and benefits
Pekny, M., & Pekna, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2013 · Cited by 934
Considering sex and gender in Alzheimer disease and other dementias
Podcasy, J. L., & Epperson, C. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/cepperson · Cited by 707
Su, D., Cui, Y., He, C., Yin, P., Bai, R., Zhu, J., Lam, J. S. T., Zhang, J., Yan, R., Zheng, X., et al. (2025) · BMJ · doi:10.1136/bmj-2024-080952 · Cited by 611
Parkinson's Disease and the Environment
Ball, N., Teo, W.-P., Chandra, S., & Chapman, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00218 · Cited by 480
Metadata
- Authors
- Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 35
- Issue
- 3
- Pages
- 370-384
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W1993241967
- Cited by
- 489
- References
- 232
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.